Prolongation of intrathecal and sciatic nerve blocks using a complex of levobupivacaine with maltosyl-β-cyclodextrin in rats

Anesthesia and Analgesia

Volumn 104, Issue 5, 2007, Pages 1121-1128

  Karashima, Ken ^a   Taniguchi, Masahiko ^a   Nakamura, Tadashi ^a   Takasaki, Mayumi ^a   Matsuo, Kanako ^b   Irikura, Mitsuru ^b   Irie, Tetsumi ^b  

^a UNIVERSITY OF MIYAZAKI   (Japan)

^b KUMAMOTO UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

BETA CYCLODEXTRIN DERIVATIVE; LEVOBUPIVACAINE; MALTOSYL BETA CYCLODEXTRIN; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DOSE TIME EFFECT RELATION; DRUG DELIVERY SYSTEM; DRUG EFFECT; DRUG SAFETY; LOCAL ANESTHESIA; MALE; MOTOR PERFORMANCE; MUSCLE TONE; NERVE BLOCK; NEUROTOXICITY; NOCICEPTION; NONHUMAN; PRIORITY JOURNAL; PROPRIOCEPTION; RAT; SCIATIC NERVE; SCIATIC NERVE BLOCK; TAIL FLICK TEST;

ANESTHESIA, SPINAL; ANIMALS; BUPIVACAINE; CYCLODEXTRINS; DRUG COMBINATIONS; INJECTIONS, SPINAL; MALE; MALTOSE; NERVE BLOCK; RATS; RATS, SPRAGUE-DAWLEY; SCIATIC NERVE; TIME FACTORS;

EID: 34247483875     PISSN: 00032999     EISSN: None     Source Type: Journal    
DOI: 10.1213/01.ane.0000260309.15034.52     Document Type: Article

References (18)

1. Aberg G. Toxicological and local anaesthetic effect of optically active isomers of two local anaesthetic compounds. Acta Pharmacol Toxicol 1972;31:272-86.
2. Huang YF, Pryor ME, Mather LE, Veering BT. Cardiovascular and central nervous system effect of intravenous levobupivacaine and bupivacaine in sheep. Anesth Analg 1998;86:797-804.
3. Bardsley H, Gristwood R, Baker H, et al. A comparison of the cardiovascular effects of levobupivacaine and rac-bupivacaine following intravenous administration to healthy volunteers. Br J Clin Pharmacol 1998;46:245-9.
4. Grant GJ, Barenholz Y, Bolotin EM, et al. A novel liposomal bupivacaine formulation to produce ultralong-acting analgesia. Anesthesiology 2004;101:133-7.
5. Uekama K, Hirayama F, Irie T. Cyclodextrin drug carrier systems. Chem Rev 1998;98:2045-76.
6. Meert TF, Melis W. Interactions between epidurally and intrathecally administered sufentanil and bupivacaine in hydroxypropyl-β-cyclodextrin in the rat. Act Anaesthesiol Belg 1992;43:79-89.
7. Yaksh TL, Jang J, Nishiuchi Y, et al. The utility of 2-hydroxypropyl- β-cyclodextrin as a vesicle for the intracerebral and intrathecal administration of drugs. Life Sci 1991;48:623-33.
8. Hylden JL, Wilcox GL. Intrathecal morphine in mice: a new technique. Eur J pharmacol 1980;67:313-16.
9. Bromage PR, Burfoot MF, Crowell DE, Pettigrew RT. Quality of epidural blockade.I. Influence of physical factors. Br J Anaesth 1964;36:342-52.
10. Thalhammer JG, Vladimirova M, Bershadsky B, Strichartz GR. Neurologic evaluation of the rat during sciatic nerve block with lidocaine. Anesthesiology 1995;82:1013-25.
11. Okada Y, Kubota Y, Koizumi K, et al. Some properties and the inclusion behavior of branched cyclodextrins. Chem Pharm Bull 1988;36:2176-85.
12. Frank DW, Gray JE, Weaver RN. Cyclodextrin nephrosis in the rat. Am J Pathol 1976;83:367-82.
13. Ohtani Y, Irie T, Uekama K, et al. Differential effects of α-, β-, and γ-cyclodextrins on human erythrocytes. Eur J Biochem 1989;186:17-22.
14. Irie T, Otagiri M, Sunada M, et al. Cyclodextrin-induced hemolysis and shape change of human erythrocytes in vitro. J Phamacobiodyn 1982;5:741-4.
15. Yamamoto M, Yoshida A, Hirayama F, Uekama K. Some physicochemical properies of branched β-cyclodextrin and their inclusion characteristics. Int J Pharm 1989;49:163-71.
16. Irie T, Uekama K. Pharmaceutical applications of cyclodextrins. III. Toxicological issues and safety evaluation. J Pharm Sci 1997;86:147-62.
17. Fréville JC, Dollo G, Le Corre P, et al. Controlled systemic absorption and increased anesthetic effect of bupivacaine following epidural administration of bupivacaine-hydroxypropyl-β-cyclodextrin complex. Pharm Res 1996;13:1576-80.
18. Dollo G, Thompson DO, Le Corre P, et al. Inclusion complexation of amide-typed local anesthetics with β-cyclodextrin and its derivatives. III. Biopharmaceutics of bupivacaine-SBE7-βCD complex following percutaneous sciatic nerve administration in rabbits. Int J Pharm 1998;164:11-19.